Fertility Preservation in Prepubertal Boys: An Experimental Approach
1 other identifier
interventional
100
1 country
1
Brief Summary
Due to remarkable advances in cancer treatments, the investigators are witnessing a growing population of long-term survivors of childhood malignancies. However, fertility in adult life may be severely impaired by gonadotoxic therapies. Since prepubertal boys cannot produce spermatozoa, banking of testicular tissue prior to gonadotoxic treatment is a crucial step towards fertility preservation for this population. Several centers around the world are now cryopreserving testicular tissue for prepubertal boys in anticipation that future technologies will allow the utilization of the banked samples for fertility restoration. Testicular tissue cryopreservation has now emerged as the leading strategy for fertility preservation in prepubertal boys before gonadotoxic treatments. Fertility restoration can theoretically be obtained after allo-transplantation of testicular tissue fragments that preserve both the SSCs and the supporting microenvironment (spermatogonial stem-cell niche).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2015
CompletedFirst Posted
Study publicly available on registry
August 20, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedAugust 20, 2015
April 1, 2015
3 years
April 19, 2015
August 19, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of cancer affected prepubertal boys who will undergo testicular cryopreservation for fertility restoration.
The investigators will report the number of cancer affected prepubertal boys that will undergo testicular cryopreservation for future fertility restoration.
The time frame for this study is defined from the date of recruitment until the date of clinical utilization of the cryopreserved tissue for fertility restoration, up to forty years
Study Arms (1)
Testicular biopsy
EXPERIMENTALCancer affected prepubertal boys will undergo testicular biopsy for testicular fragments cryopreservation. The biopsy will be performed by an attending urologist, before any gonadotoxic therapy is initiated. Testicular biopsy specimens will be divided immediately on the operating table. Two thirds of the specimen will be cryopreserved for potential use by the patient at a later date and will have the patient's details and will stay at the sperm bank of Hadassah Medical Center. The other third of specimen will be used for research purposes in an effort to advance the science of isolating and culturing human SSC's for fertility research.
Interventions
An open testicular biopsy will be performed by an attending urologist under general anesthesia.
Eligibility Criteria
You may qualify if:
- Prepubertal males newly diagnosed with high risk malignancy (not testicular), and whose treatment will include therapy with agents that place the boy at high risk for infertility are also eligible.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, Israel
Related Publications (1)
Kabiri D, Safrai M, Gropp M, Hidas G, Mordechai-Daniel T, Meir K, Revel A, Imbar T, Reubinoff B. Establishment of a controlled slow freezing-based approach for experimental clinical cryopreservation of human prepubertal testicular tissues. F S Rep. 2021 Nov 5;3(1):47-56. doi: 10.1016/j.xfre.2021.11.001. eCollection 2022 Mar.
PMID: 35386499DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Doron Kabiri, MD
Hadassah Hebrew Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2015
First Posted
August 20, 2015
Study Start
November 1, 2015
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
August 20, 2015
Record last verified: 2015-04